Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Assets (2016 - 2025)

Veracyte (VCYT) has disclosed Non-Current Assets for 14 consecutive years, with $917.6 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 1.09% to $917.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Dec 2025, up 0.79% year-over-year, with the annual reading at $917.6 million for FY2025, 1.09% down from the prior year.
  • Non-Current Assets hit $917.6 million in Q4 2025 for Veracyte, roughly flat from $918.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $957.0 million in Q3 2021 to a low of $656.1 million in Q2 2021.
  • Historically, Non-Current Assets has averaged $885.9 million across 5 years, with a median of $911.4 million in 2024.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 1059.4% in 2021 and later dropped 8.65% in 2023.
  • Year by year, Non-Current Assets stood at $944.7 million in 2021, then decreased by 3.91% to $907.8 million in 2022, then dropped by 8.65% to $829.3 million in 2023, then grew by 11.88% to $927.8 million in 2024, then dropped by 1.09% to $917.6 million in 2025.
  • Business Quant data shows Non-Current Assets for VCYT at $917.6 million in Q4 2025, $918.6 million in Q3 2025, and $929.4 million in Q2 2025.